Environment

Resilient and sustainable operations

We operate responsibly at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services. 

Watch Our Purpose in action: Resilient and sustainable operations to see how Cencora puts corporate responsibility into practice — advancing responsible, resilient operations that support reliable healthcare delivery.

Available in English only.

We bring innovation and efficiency to the supply chain

We operate at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services. To strengthen business continuity, we prioritize resilience by implementing advanced forecasting systems, equipping facilities with backup power sources, and conducting regular emergency preparedness training to mitigate the impact of severe weather on our operations.

Guided by our commitment to operating sustainably, we invest in innovative solutions for our buildings, product packaging, and transportation, collaborating with partners to amplify our impact. We align our corporate responsibility reporting with leading global frameworks.

Progress on our Science-Based Targets

Cencora’s climate strategy is guided by validated near-term Science-Based Targets (SBTs), with the following goals:
54.6%
De absolute marktgebaseerde emissies van scope 1 en 2 met 54,6 procent verminderen tegen fiscaal 2032, vergeleken met onze opnieuw berekende waarden voor fiscaal 2019. De herberekening van de emissies in het referentiejaar in 2025 moest een weerspiegeling zijn van de verbeterde nauwkeurigheid en integratie van gegevens in wereldwijde activiteiten, waardoor de integriteit en vergelijkbaarheid van onze doelstellingen in de loop van de tijd zouden worden verbeterd.
82%
82 procent van onze leveranciers betrekken bij hun uitgaven om hun eigen wetenschappelijk onderbouwde doelen te stellen tegen 2027, Erkennend dat het overgrote deel van onze uitstoot afkomstig is van onze wereldwijde toeleveringsketen.

Product integrity and patient safety

Cencora’s global infrastructure and technology support product integrity, prioritize patient safety, and drive a secure pharmaceutical supply chain. In fiscal 2025, we advanced product traceability, optimized storage conditions, and enhanced reusable packaging with temperature monitoring to safeguard shipments. Through proactive partnerships and innovative solutions, we look every day for both micro and macro opportunities to improve our operations, support healthcare providers, and protect patients worldwide.
Na meer dan 12 jaar voorbereiding is Cencora er trots op een voortrekkersrol te spelen bij de implementatie van de Drug Supply Chain Security Act (DSCSA) in onze Amerikaanse activiteiten.
Deze federale wet verbetert de traceerbaarheid van geneesmiddelen op recept in de hele toeleveringsketen en beschermt patiënten tegen nagemaakte en onwettige producten.
Onze teams hebben doelgericht gewerkt aan de voorbereiding op deze mijlpaal door nieuwe apparatuur te installeren, systemen te ontwikkelen, de industrie voor te lichten en samen te werken met handelspartners, waaronder fabrikanten, distributeurs en leveranciers.

Supplier Engagement and Resiliency

At Cencora, we are united in our responsibility to create healthier futures. Our Supplier Engagement & Resiliency Program (SE&R) is an essential part of this mission, reflecting our commitment to fostering belonging and innovation in the global communities we serve. This program, embedded within our Strategic Global Sourcing Team (SGS), partners with small and disadvantaged businesses, aiming to drive economic growth, create opportunities, and deliver impactful change. 

Aligned with our Corporate Responsibility principles, Cencora’s SE&R Program is designed to support sustainable economic impact. By increasing revenues for small and disadvantaged businesses, creating jobs in underserved communities, and driving innovation, we contribute to building a more sustainable global economy.

Gezondheid en veiligheid van teamleden

De gezondheid en veiligheid van onze teamleden is een hoeksteen van ons doel in de praktijk. Het afgelopen jaar hebben we aanzienlijke vooruitgang geboekt bij het verbeteren van veiligheidsprotocollen, het verbeteren van de werkcultuur en het bevorderen van een omgeving waarin elk teamlid zich gesteund en beschermd voelt.

Voorbereiding op noodsituaties en rampenbestrijding

Het leveren van levensreddende medicijnen is een verantwoordelijkheid die betrouwbaarheid vereist, zelfs in de meest uitdagende omstandigheden. Onze wereldwijde teams hebben met niet-aflatende toewijding gewerkt om ervoor te zorgen dat patiënten essentiële therapieën krijgen, ongeacht de verstoringen veroorzaakt door natuurrampen, extreme weersomstandigheden of andere noodsituaties.

Cybersecurity, gegevensbescherming en privacy

Cencora zet zich in voor robuuste cyberbeveiliging, houdt actief toezicht op inbreuken en werkt aan voldoen aan de naleving van regelgeving zoals de Algemene Verordening Gegevensbescherming (AVG), de Gezondheidsverordening Verzekering Portability and Accountability Act (HIPAA) en de California Consumer Privacy Act (CCPA).

Helping combat the opioid addiction

Cencora’s wholesale pharmaceutical distribution business plays a key, but specific, role of providing safe access to thousands of important medications to enable healthcare providers to serve patients with a wide array of clinical needs across the healthcare spectrum. A small part of this includes the distribution of opioids and other controlled substances from manufacturers to neighborhood pharmacies and pharmacy chains, as well as to hospitals, nursing homes, hospices, and other clinical settings. As opioid addiction continues to impact patients and families, we are taking a proactive, collaborative approach to help combat opioid misuse and abuse while also seeking to ensure access for patients with legitimate medical needs.

We have taken substantial steps to help prevent the diversion of controlled substances. Cencora has a sophisticated diversion control program through which the Company provides daily reports to the United States Drug Enforcement Administration about the quantity, type, and receiving pharmacy of every order of controlled substances that we distribute. We also work closely with other healthcare stakeholders, government entities, civic organizations, law enforcement agencies, individuals our nonprofit partners to support prescription drug safety and mental health resources in local communities. We continuously evaluate, enhance, strengthen and expand the proven measures that we have implemented to maintain the integrity of every order we ship.

Distributors such as Cencora do not manufacture or create supply or demand for opioids. The distribution of opioid medicines represents less than one percent of our annual revenue, and we do not offer our sales team members incentives based on opioid sales.

More details on our efforts to ensure safe and secure distribution, maintain operational integrity, and support legislation can be found in our periodic reports filed with the U.S. Securities and Exchange Commission at www.sec.gov and on the investor relations section of our website at investor.cencora.com/overview/default.aspx

Explore our other corporate responsibility pillars

Mensen

Betrokken collega's

We zetten onze mensen op de eerste plaats door open samen te werken binnen onze organisatie om een betrokken werkomgeving te bevorderen en hoge ethische en nalevingsnormen te handhaven.

Bedrijfsleven en gemeenschap

Gezonde gemeenschappen

We streven ernaar de toegang tot gezondheidszorg te verbreden en de gezondheidsresultaten in gemeenschappen en voor onze klanten over de hele wereld te versnellen.

View the report

At Cencora, we are united in our responsibility to create healthier futures.
 
Available in English only.

Content index

View additional metrics easily accessible in our content index.